期刊文献+

乙型肝炎病毒X基因真核表达载体的构建 被引量:1

Construction of Hepatitis B Virus X Gene Eukaryotic Expression Vector
下载PDF
导出
摘要 目的:构建HBVX基因与pCI-neo相融合的高效真核表达载体。方法:设计并合成HBVX基因的引物,以HBVDNA阳性血清PCR扩增得到HBVX基因全序列,将X基因连接到真核表达载体pCI-neo上后,酶切图谱分析、PCR检测和扩增产物序列分析等,鉴定所构建的真核表达载体。结果:以重组载体为模板扩增得到的片段大小与已知HBVX基因大小相同,酶切也得到目的基因片段,测序结果也显示与已知X基因序列相同。结论:成功构建了HBVX基因的真核表达载体,为进一步研究HBVX基因及其产物的功能奠定了基础。 Objective:To construct a highly effective eukaryotic expression vector pCI-neo with HBV X gene(pCI-neo-X).Methods:HBV DNA was extracted from the HBV DNA positive serum.HBV X gene was amplified by PCR,and identified by gelose electrophoresis analysis.The PCR products and the eukaryotic expression vectors pCI-neo were digested by restriction endonucleases,then the digested X gene was inserted into the digested eukaryotic expression vector.After screening,the positive recombinants were picked out.Results:PCR analysis showed that the HBV X gene was successfully inserted into pCI-neo vector.Conclusion:The construction of the eukaryotic expression vector pCI-neo will lay solid foundations for further study of HBVX gene.
出处 《长江大学学报(自科版)(下旬)》 CAS 2009年第1期6-8,共3页 Journal of Yangtze University
关键词 乙型肝炎病毒 X基因 真核表达载体 Hepatitis B virus X gene Eukaryotic expression vector
  • 相关文献

参考文献5

二级参考文献25

  • 1李建民,陈薇,安小平,李冰,樊英茹,郝晓萌,左少军,童贻刚.基孔肯亚病毒人鼠嵌合抗体在CHO细胞中的表达和活性研究[J].中华微生物学和免疫学杂志,2004,24(10):785-789. 被引量:1
  • 2李红,万军,李园,朱美玲,赵坡.中国人结肠癌染色体12p12-13杂合性丢失的研究[J].中华医学遗传学杂志,2005,22(6):694-697. 被引量:5
  • 3Aladjem MI, Brody LL, O'Gorman S, et al. Positive selection of FLP-mediated unequal sister chromatid exchange products in mammalian cells[J]. Mol Cell Biol, 1997, 17(20): 857 -861.
  • 4Sauer B. Site-specific recombination: developments and applications [J]. Curr Opin Biotechnol , 1994, 5(5): 521 -527.
  • 5萨姆布鲁克J 弗里奇EF 译).曼尼阿蒂斯T(金冬雁,分子克隆实验指南[M](第2版)[M].北京:科学出版社,1996.42-59,880-889.
  • 6Chun-Bao Guo,Ying-Cun Li,Xian-Qing Jin.Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo[J].Cancer Chemotherapy and Pharmacology.2006(1)
  • 7Jing Jin,Feng-Peng Wang,Huailing Wei,Gengtao Liu.Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine[J].Cancer Chemotherapy and Pharmacology.2005(2)
  • 8Chang G,Roth C B.Structure of MsbA from E.coli : A homolog of the multidrug resistance ATP Binding Cassette(ABC)transporters[].Science.2001
  • 9Lasagna N,Fantappie O,Solazzo M,Morbidelli L,Marchetti S,Cipriani G,Ziche M,Mazzanti R.Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidmg resistance-induced angiogenesis in hepatocellular carcinoma cell lines[].Cancer Research.2006
  • 10Barraud,L.,Merle,P.,Soma,E.,Lefran?ois,L.,Guerret,S.,Chevallier,M.,Dubernet,C.,Couvreur,P.,Trepo,C.,Vitvitski,L.Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo[].Journal of Hepatology.2005

共引文献26

同被引文献16

  • 1Koike K. Hepatitis B virus X gene is implicated in liver carcinogenesis [J]. Cancer Lett, 2009, 286 (1): 60-68.
  • 2Chramedei K, Morbt N, Pfeifer G, et al. MicroRNA -21 targets tumor suppressor genes ANP32A and SMARCA4 [ J ]. Oncogene, 2011, 30 (26): 2975-2985.
  • 3Yamamichi N, Shimomura R, lnada K, et al. Locked nucleic acid in situhybfidization analysis of miR- 21 expression during colorectal cancer development [J]. Clin Cancer Res, 2009, 15 (12): 4009-4016.
  • 4Smeets A, Daemen A, Vanden Bempt I, et al. Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs [J]. Breast Cancer Res Treat, 2011, 129 (3) : 767 -776.
  • 5Schramedei K, Morbt N, Pfeifer G, et al. MicroRNA -21 targets tumor suppressor genes ANP32A and SMARCA4 [ J]. Oncogene, 2011, 30 (26): 2975-2985.
  • 6Resnike KE, Alder H, Hagan JP, et al. The detection of differential- ly expressed microRNAs from the serum of ovariancancer patients using a novel real time PCR platform [J]. Gynecol Oncol, 2009, 112 (1): 55-59.
  • 7Zhang HL, Yang LF, Zhu Y, et al. Serum miRNA-21: elevated levels in patients with metastatic hormone - refractory prostate cancer andpotential predictive factor for the efficacy of docetaxel - based chem- otherapy [J]. Prostate, 2011, 71 (3): 326-331.
  • 8Ribas J, Lupold SE. The transcriptional regulation of miR -21, it smuhiple transcripts, and their implication in prostate cancer [ J]. Cell Cycle, 2010, 9(5): 923-929.
  • 9Yu DC,Li QG, Ding XW, et al. Circulating MieroRNAs: potential bio- markers for cancer[J]. Int J Mol Sci,2011,12(10) :2055 -2063.
  • 10Harley ME, Patrick DM, Garcia MR., et al. Modulation of K-ras- dependent lung tumorigenesis by MicroRNA - 21 [ J]. Cancer Cell, 2010, 18 (3): 282-293.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部